Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
31 Jul 2019
Historique:
received: 24 05 2019
revised: 17 07 2019
accepted: 26 07 2019
entrez: 3 8 2019
pubmed: 3 8 2019
medline: 4 1 2020
Statut: epublish

Résumé

Phosphodiesterase 2A (PDE2A) is highly expressed in distinct areas of the brain, which are known to be related to neuropsychiatric diseases. The development of suitable PDE2A tracers for Positron Emission Tomography (PET) would permit the

Identifiants

pubmed: 31370274
pii: molecules24152791
doi: 10.3390/molecules24152791
pmc: PMC6696243
pii:
doi:

Substances chimiques

Ligands 0
Radiopharmaceuticals 0
Triazines 0
Cyclic Nucleotide Phosphodiesterases, Type 2 EC 3.1.4.17

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SCHE 1825/3-1
Organisme : Indonesia Ministry of Research and Technology-Program for Research and Innovation in Science and Technology Project (RISET-Pro)
ID : World Bank Loan No: 8245-ID

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Angew Chem Int Ed Engl. 2006 Nov 27;45(46):7736-9
pubmed: 17013952
Ernst Schering Res Found Workshop. 2007;(62):113-57
pubmed: 17172154
Chem Biodivers. 2007 Mar;4(3):257-405
pubmed: 17372942
Annu Rev Biochem. 2007;76:481-511
pubmed: 17376027
J Histochem Cytochem. 2009 Oct;57(10):933-49
pubmed: 19506089
Neuropharmacology. 2010 Nov;59(6):367-74
pubmed: 20493887
Physiol Rev. 2011 Apr;91(2):651-90
pubmed: 21527734
Br J Pharmacol. 2012 Mar;165(5):1288-305
pubmed: 22014080
Expert Opin Ther Pat. 2012 Apr;22(4):349-54
pubmed: 22475506
Bioorg Med Chem Lett. 2012 Sep 15;22(18):5876-84
pubmed: 22902656
Neuroscience. 2012 Dec 13;226:145-55
pubmed: 23000621
J Am Chem Soc. 2013 Aug 14;135(32):11708-11
pubmed: 23899287
Bioorg Med Chem Lett. 2013 Dec 15;23(24):6522-7
pubmed: 24189054
Cancers (Basel). 2014 Feb 26;6(1):436-58
pubmed: 24577242
Nat Rev Drug Discov. 2014 Apr;13(4):290-314
pubmed: 24687066
ACS Med Chem Lett. 2014 Jul 22;5(9):1049-53
pubmed: 25221665
Eur J Pharmacol. 2015 Aug 15;761:79-85
pubmed: 25941078
Molecules. 2015 May 26;20(6):9591-615
pubmed: 26016549
Eur J Med Chem. 2016 Jan 1;107:97-108
pubmed: 26562545
Pharmaceuticals (Basel). 2016 Apr 21;9(2):null
pubmed: 27110797
Molecules. 2016 May 19;21(5):
pubmed: 27213312
Expert Opin Ther Pat. 2016 Aug;26(8):933-46
pubmed: 27321640
Molecules. 2016 Sep 08;21(9):
pubmed: 27617996
Chem Rev. 2016 Oct 12;116(19):12150-12233
pubmed: 27631342
J Labelled Comp Radiopharm. 2017 Jan;60(1):36-48
pubmed: 27896836
J Med Chem. 2017 Mar 9;60(5):2037-2051
pubmed: 28165743
Acta Crystallogr B Struct Sci Cryst Eng Mater. 2017 Jun 1;73(Pt 3):474-488
pubmed: 28572557
J Med Chem. 2017 Jul 13;60(13):5673-5698
pubmed: 28574706
J Med Chem. 2017 Sep 28;60(18):7658-7676
pubmed: 28759228
J Med Chem. 2018 Mar 22;61(6):2166-2210
pubmed: 28850227
J Med Chem. 2018 Feb 8;61(3):1001-1018
pubmed: 29293004
Molecules. 2018 Mar 02;23(3):null
pubmed: 29498659
J Med Chem. 2018 Sep 13;61(17):7754-7766
pubmed: 30070482
Proc Natl Acad Sci U S A. 1972 Jul;69(7):1791-5
pubmed: 4340159

Auteurs

Rien Ritawidya (R)

Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceuticals Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig 04318, Germany. r.ritawidya@hzdr.de.
Center for Radioisotope and Radiopharmaceutical Technology, National Nuclear and Energy Agency (BATAN), Puspiptek Area, Serpong, South Tangerang, Indonesia. r.ritawidya@hzdr.de.

Friedrich-Alexander Ludwig (FA)

Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceuticals Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig 04318, Germany.

Detlef Briel (D)

Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Faculty of Medicine, Leipzig University, Brüderstraße 34, Leipzig 04103, Germany.

Peter Brust (P)

Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceuticals Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig 04318, Germany.

Matthias Scheunemann (M)

Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceuticals Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig 04318, Germany. rienrita@batan.go.id.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH